|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 30 November 2021, 10:07. The announcement is marked as price sensitive, and is 41 page(s) in length and 9.34MB in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 2.594% short sold according to ASIC data. It was ranked the 66th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| AGM Chairman address and CEO presentation | 30 November 2021, 10:07 |
| Positive DEP phase 2 interim results in prostate cancer | 25 November 2021, 11:03 |
| Jobkeeper s323DB(1) notice | 11 November 2021, 14:19 |
| Starpharma to present at Bell Potter Healthcare Conference | 9 November 2021, 13:20 |
You must be logged in to post a reply.
Starpharma Holdings 